ELLINGTON MANAGEMENT GROUP LLC - CELLDEX THERAPEUTICS INC NEW ownership

Back to all holdings Add to watchlist

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 199 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Links
Filings
External links
Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2015$131,000
-39.1%
12,440
+5.4%
0.04%
-47.9%
Q4 2014$215,000
+18.1%
11,800
+14.6%
0.07%
+34.0%
Q1 2014$182,000
-51.2%
10,300
-56.9%
0.05%
-25.4%
Q2 2013$373,000–23,900–0.07%–
 Download
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders